Viral Hepatitis
Copyright ©The Author(s) 2004.
World J Gastroenterol. Jul 1, 2004; 10(13): 1893-1897
Published online Jul 1, 2004. doi: 10.3748/wjg.v10.i13.1893
Table 1 Characteristics of SENV positive and SENV negative patients
SENV positive (n = 21)SENV negative (n = 74)P value
Median age (yr)42 ± 1242 ± 120.991
Male, m (%)13 (62%)46 (62%)1.002
Median baseline ALT (IU/L )81 ± 10969 ± 600.561
Pretreated, n (%)3 (14%)10 (14%)1.002
Hepatitis C genotype, n (%)
1, 416 (76%)51 (69%)0.602
2, 35 (24%)21 (28%)0.792
Undetermined0 (0%)2 (3%)
PEG-IFN11 (52%)35 (47%)0.812
Sustained HCV response to therapy11 (52%)37 (50%)1.002
Table 2 Clinical, biochemical and viral characteristics in rela-tion to HCV response to combination therapy
Sustained response (n = 48)No sustained response (n = 47)P value
Male, n (%)30 (63%)29 (62%)0.341
Age (yr )39 ± 1145 ± 11< 0.012
ALT70 ± 7874 ± 680.542
HCV genotype, n (%)
1 or 430 (63%)37 (79%)
2 or 316 (33%)10 (21%)0.161
Undetermined2 (4%)
SEN positive, n (%)10 (21%)11 (23%)0.811
SENV H-DNA393 ± 297523 ± 4520.482
(copies/mL)
Table 3 Clinical and virological characteristics of patients coinfected with HCV and SENV
NoAge (yr)SEXALT (U/L)HCVSENVSENV HHCVSEN V
genotypegenotypecopies/mLresponseresponse
160M621H218YesYes
247F261D/H74NoYes
341F411D-YesNo
431M261H208YesYes
559F621H1304NoNo
647F1692H1184NoNo
731M261H484YesNo
828M321H308YesYes
963M1681H310NoNo
1059F1214H338NoYes
1135F422H38YesYes
1236M431H532NoYes
1341M241H848YesYes
1441M1801D-YesYes
1532F5133H224YesYes
1644F363D-YesYes
1728M282H814YesYes
1842M401H74NoYes
1937M324H230NoYes
2062F411H662NoYes
Table 4 Clinical and virological parameter of SENV re-sponse to combination therapy in 20 HCV/SENV-coinfected patients
SENV response (15)SENV nonresponse (5)P
Age (yr, mean)41 ± 1248 ± 130.231
Male10 (63%)3 (60%)1.02
ALT85 ± 6180 ± 1230.351
SENV H-DNA (copies/mL)371 ± 276 (n = 13)820 ± 497 (n = 4)0.051